Munafa Stock Market Course + Intraday & FNO calls 
Audentes Therapeutics (BOLD) Technical (Analysis) Reports Audentes Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Audentes Therapeutics (BOLD)
Technical Analysis Report for USA stock BOLD Audentes Therapeutics. Dated: 30 Jul 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock BOLD Audentes Therapeutics then click here. or read Experts views on Audentes Therapeutics or Forecast & share price targets of Audentes Therapeutics
Audentes Therapeutics Opened at 2.49 and Closed at: 2.50, which is 0.8% of previous session's close. It moved within a range of 2.49 and 2.55
The session was a Bullish session with an average volume of 99000, which is 27.58% of previous session's volumes.
- The stock has shown an up move, and its mid term trend is also positive and in an uptrend.
A Golden cross was found 5 days back on short term averages
A Dead cross was found 9 days back on short term averages
Support for tomorrow is 2.5 and resistance for tomorrow is 2.56
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 2.48, 2.45 resistance for tomorrow's hourly charts is 2.54, 2.57
10 Day SMA for Audentes Therapeutics (BOLD) is 2.5 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Audentes Therapeutics (BOLD) is 2.49 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Audentes Therapeutics (BOLD) is 2.03 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 1.69 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Audentes Therapeutics is 1.45 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Audentes Therapeutics is at 2.49 and 200 DMA is at 1.45, while 50 DMA and 100 DMA are at 2.03 and 1.69 respectively
Audentes Therapeutics (BOLD) moving average of 20 SMA is at 2.49 and 20 EMA is at 2.44
| Date | Closing Price | 20 SMA | 20 EMA |
| 30 Thu Jul | 2.50 | 2.49 | 2.44 |
| 29 Wed Jul | 2.48 | 2.49 | 2.43 |
| 28 Tue Jul | 2.47 | 2.49 | 2.42 |
| 27 Mon Jul | 2.48 | 2.49 | 2.42 |
| 24 Fri Jul | 2.57 | 2.49 | 2.41 |
| 24 Fri Jul | 2.57 | 2.49 | 2.39 |
Audentes Therapeutics (BOLD) moving average of 50 SMA is at 2.03 and 50 EMA is at 2.13
| Date | Closing Price | 50 SMA | 50 EMA |
| 30 Thu Jul | 2.50 | 2.03 | 2.13 |
| 29 Wed Jul | 2.48 | 2.01 | 2.12 |
| 28 Tue Jul | 2.47 | 1.98 | 2.11 |
| 27 Mon Jul | 2.48 | 1.97 | 2.1 |
| 24 Fri Jul | 2.57 | 1.95 | 2.08 |
| 24 Fri Jul | 2.57 | 1.93 | 2.06 |
Audentes Therapeutics (BOLD) moving average of 100 SMA is at 1.69 and 100 EMA is at 1.85
| Date | Closing Price | 100 SMA | 100 EMA |
| 30 Thu Jul | 2.50 | 1.69 | 1.85 |
| 29 Wed Jul | 2.48 | 1.67 | 1.84 |
| 28 Tue Jul | 2.47 | 1.66 | 1.83 |
| 27 Mon Jul | 2.48 | 1.65 | 1.82 |
| 24 Fri Jul | 2.57 | 1.63 | 1.81 |
| 24 Fri Jul | 2.57 | 1.62 | 1.79 |
Audentes Therapeutics (BOLD) moving average of 200 SMA is at 1.45 and 200 EMA is at 1.81
| Date | Closing Price | 200 SMA | 200 EMA |
| 30 Thu Jul | 2.50 | 1.45 | 1.81 |
| 29 Wed Jul | 2.48 | 1.45 | 1.8 |
| 28 Tue Jul | 2.47 | 1.44 | 1.79 |
| 27 Mon Jul | 2.48 | 1.43 | 1.78 |
| 24 Fri Jul | 2.57 | 1.43 | 1.77 |
| 24 Fri Jul | 2.57 | 1.42 | 1.76 |
Audentes Therapeutics has performed better than Tiziana Life in short term. Holding Audentes Therapeutics could be a better choice for now!
Audentes Therapeutics has performed better than Prothena Corporation in short term. Holding Audentes Therapeutics could be a better choice for now!
Phio Pharmaceuticals has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Phio Pharmaceuticals, about 4.04% more returns!
Merit Medical has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Merit Medical, about 16.66% more returns!
Medpace Holdings has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Medpace Holdings, about 2.34% more returns!
Lexicon Pharmaceuticals has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Lexicon Pharmaceuticals, about 0.86% more returns!
Audentes Therapeutics has performed better than Lipocine Inc in short term. Holding Audentes Therapeutics could be a better choice for now!
Audentes Therapeutics has performed better than Luminex Corporation in short term. Holding Audentes Therapeutics could be a better choice for now!
Audentes Therapeutics has performed better than Kala Pharmaceuticals in short term. Holding Audentes Therapeutics could be a better choice for now!
Audentes Therapeutics has performed better than Henry Schein in short term. Holding Audentes Therapeutics could be a better choice for now!
Gilead Sciences has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Gilead Sciences, about 1.29% more returns!
Audentes Therapeutics has performed better than Equillium Inc in short term. Holding Audentes Therapeutics could be a better choice for now!
Audentes Therapeutics has performed better than Curis Inc in short term. Holding Audentes Therapeutics could be a better choice for now!
Cumberland Pharmaceuticals has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Cumberland Pharmaceuticals, about 9.25% more returns!
Audentes Therapeutics has performed better than Cerus Corporation in short term. Holding Audentes Therapeutics could be a better choice for now!
Audentes Therapeutics has performed better than Aytu Bioscience in short term. Holding Audentes Therapeutics could be a better choice for now!
Audentes Therapeutics has performed better than Amarin Corporation in short term. Holding Audentes Therapeutics could be a better choice for now!
Audentes Therapeutics has performed better than Akari Therapeutics in short term. Holding Audentes Therapeutics could be a better choice for now!
Akebia Therapeutics has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Akebia Therapeutics, about 3.85% more returns!
Audentes Therapeutics Technical analysis of indicators
Price action analysis of Audentes Therapeutics (BOLD) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
ADX buy sell signal for Audentes Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Audentes Therapeutics in short term but the sell signal is initial and weak.
Audentes Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Audentes Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Audentes Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.52 and Audentes Therapeutics BOLD stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Audentes Therapeutics BOLD stock. Volume based technical analysis of Audentes Therapeutics BOLD stock is negative.
Audentes Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock BOLD Audentes Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And BOLD Experts View which covers a lot of information including buying and selling signals
BOLD future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Audentes Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Audentes Therapeutics (BOLD) Technical (Analysis) Reports Audentes Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
